Title Credit Type Event date Cost
Safety Considerations for Oligonucleotides
    • 0.50 Participation
 Enduring $25.00
Immuno-oncology Enduring $25.00
Immuno-oncology Enduring $25.00
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
Immunophenotyping
    • 0.50 Participation
 Enduring $25.00
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
Systems Biology Applied to Immune Safety
    • 0.50 Participation
 Enduring $25.00
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
Immunogenicity characterization tools (ADAs, complement, immune complexes)
    • 0.50 Participation
 Enduring $25.00
Immunopathology: evaluation, assessment, and considerations Enduring $25.00
Immunopathology: evaluation, assessment, and considerations Enduring $25.00

Pages